Huy le, DO
Family Medicine · Newark, DENPI 1831170703
Payments from drug & device makers
Across 536 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$1K
- Novo Nordisk$1K
- GSK$1K
- Abbott$929
- Lilly USA, LLC$895
- plus $3K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 103 | $2,001 |
| AstraZeneca | 73 | $1,455 |
| Novo Nordisk | 96 | $1,390 |
| GSK | 65 | $1,091 |
| Abbott | 26 | $929 |
| Lilly USA, LLC | 47 | $895 |
| Astellas Pharma US Inc | 17 | $570 |
| Boehringer Ingelheim | 19 | $376 |
| Merck | 15 | $311 |
| Sanofi-aventis U.S. LLC | 12 | $262 |
| Johnson & Johnson | 13 | $207 |
| Sanofi Pasteur Inc. | 7 | $121 |
| Pfizer | 6 | $89 |
| VBI Vaccine (delaware) Inc. | 3 | $80 |
| Medtronic | 1 | $77 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $74 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $64 |
| Eisai Inc. | 3 | $57 |
| Amarin Pharma, Inc. | 4 | $55 |
| Ultragenyx Pharmaceutical Inc. | 2 | $47 |
| Tactile Systems Technology Inc | 1 | $40 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Exact Sciences | 2 | $37 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Mannkind Corporation | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Shire North American Group Inc | 1 | $19 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Seqirus USA Inc | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Amgen | 1 | $11 |
How this compares
$10,470 in reported general payments places this provider in the 90th percentile of 352 family medicine providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Newark
- Michelle PapaNewark$23K
- Ian MyersNewark$17K
- Robert WinterNewark$12K
- Judy LimNewark$12K
- Arlen StoneNewark$10K
- Imelyn LaheyNewark$8K
- Angela Davis BrownNewark$8K
- Robert CallahanNewark$7K
- George NameyNewark$6K
- William FunkNewark$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.